ERICA – European Rare dIsease research Coordination and support Action

Project Acronym ERICA
Funding Program H2020
Budget 2,313,808.75
Starting-end date March 1, 2021 – February 28, 2025

About ERICA 

Rare diseases are defined as diseases that affect not more than 1 person per 2000 in the European population. While individual rare diseases affect only a small percentage of the population, they collectively affect up to 30 million people in the EU. Through knowledge sharing, engagement with stakeholders in the rare disease domain and assembly of transdisciplinary research groups working across the global health spectrum ERICA strives to reach the following goals:  

  • new intra- and inter-ERN rare disease competitive networks;  
  • effective data collection strategies;  
  • better patient involvement;  
  • enhanced quality and impact of clinical trials;  
  • increased awareness of ERN’s innovation potential. 

Through integration of European Reference Networks (ERN) research activities, outreach to European research infrastructures to synergistically increase impact and innovation ERICA will strengthen the research and innovation capacity of the ERNs. This will result in safe, accessible and efficient access of therapies for the benefit of patients suffering from rare diseases and conditions. 

ERICA Consortium 

To facilitate access to high quality cross-border healthcare and promote and foster cooperation on rare disease healthcare between member states, 24 ERN are currently active. The aim of the ERICA consortium, in which all 24 ERNs take part, is to build on the strength of the individual ERNs and create a platform that integrates all ERN’s research and innovation capacity. 

EATRIS will have a role in supporting the process of translating the discoveries made in the clinic and laboratory into new diagnostic and therapeutic interventions for rare diseases. Successful translation requires both interdisciplinary and inter-sectoral collaboration, as well as access to cutting edge analytical technologies, preclinical models and assays, and bio-samples and dataIn light of this, EATRIS will contribute to Capacity building – by running workshops and webinars focused on helping researchers understand the translational pathway and the project’s Innovation strategy – in order to maximise the synergies within and across ERNs with respect to innovation and collaboration.